BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 21078884)

  • 1. Differential signaling of cysteinyl leukotrienes and a novel cysteinyl leukotriene receptor 2 (CysLT₂) agonist, N-methyl-leukotriene C₄, in calcium reporter and β arrestin assays.
    Yan D; Stocco R; Sawyer N; Nesheim ME; Abramovitz M; Funk CD
    Mol Pharmacol; 2011 Feb; 79(2):270-8. PubMed ID: 21078884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A selective cysteinyl leukotriene receptor 2 antagonist blocks myocardial ischemia/reperfusion injury and vascular permeability in mice.
    Ni NC; Yan D; Ballantyne LL; Barajas-Espinosa A; St Amand T; Pratt DA; Funk CD
    J Pharmacol Exp Ther; 2011 Dec; 339(3):768-78. PubMed ID: 21903747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cysteinyl leukotrienes and their receptors: molecular and functional characteristics.
    Singh RK; Gupta S; Dastidar S; Ray A
    Pharmacology; 2010; 85(6):336-49. PubMed ID: 20516735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the human cysteinyl leukotriene 2 receptor.
    Heise CE; O'Dowd BF; Figueroa DJ; Sawyer N; Nguyen T; Im DS; Stocco R; Bellefeuille JN; Abramovitz M; Cheng R; Williams DL; Zeng Z; Liu Q; Ma L; Clements MK; Coulombe N; Liu Y; Austin CP; George SR; O'Neill GP; Metters KM; Lynch KR; Evans JF
    J Biol Chem; 2000 Sep; 275(39):30531-6. PubMed ID: 10851239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional recognition of a distinct receptor preferential for leukotriene E4 in mice lacking the cysteinyl leukotriene 1 and 2 receptors.
    Maekawa A; Kanaoka Y; Xing W; Austen KF
    Proc Natl Acad Sci U S A; 2008 Oct; 105(43):16695-700. PubMed ID: 18931305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological evidence for a novel cysteinyl-leukotriene receptor subtype in human pulmonary artery smooth muscle.
    Walch L; Norel X; Bäck M; Gascard JP; Dahlén SE; Brink C
    Br J Pharmacol; 2002 Dec; 137(8):1339-45. PubMed ID: 12466244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human T(H)2 cells respond to cysteinyl leukotrienes through selective expression of cysteinyl leukotriene receptor 1.
    Parmentier CN; Fuerst E; McDonald J; Bowen H; Lee TH; Pease JE; Woszczek G; Cousins DJ
    J Allergy Clin Immunol; 2012 Apr; 129(4):1136-42. PubMed ID: 22391114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An alternative pathway for metabolism of leukotriene D(4): effects on contractions to cysteinyl-leukotrienes in the guinea-pig trachea.
    Bäck M; Kumlin M; Cotgreave IA; Dahlén SE
    Br J Pharmacol; 2001 Aug; 133(7):1134-44. PubMed ID: 11487525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The molecular characterization and tissue distribution of the human cysteinyl leukotriene CysLT(2) receptor.
    Takasaki J; Kamohara M; Matsumoto M; Saito T; Sugimoto T; Ohishi T; Ishii H; Ota T; Nishikawa T; Kawai Y; Masuho Y; Isogai T; Suzuki Y; Sugano S; Furuichi K
    Biochem Biophys Res Commun; 2000 Aug; 274(2):316-22. PubMed ID: 10913337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterisation of P2Y(12) receptor responsiveness to cysteinyl leukotrienes.
    Foster HR; Fuerst E; Lee TH; Cousins DJ; Woszczek G
    PLoS One; 2013; 8(3):e58305. PubMed ID: 23472176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular cloning and characterization of a second human cysteinyl leukotriene receptor: discovery of a subtype selective agonist.
    Nothacker HP; Wang Z; Zhu Y; Reinscheid RK; Lin SH; Civelli O
    Mol Pharmacol; 2000 Dec; 58(6):1601-8. PubMed ID: 11093801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The murine cysteinyl leukotriene 2 (CysLT2) receptor. cDNA and genomic cloning, alternative splicing, and in vitro characterization.
    Hui Y; Yang G; Galczenski H; Figueroa DJ; Austin CP; Copeland NG; Gilbert DJ; Jenkins NA; Funk CD
    J Biol Chem; 2001 Dec; 276(50):47489-95. PubMed ID: 11591709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. International Union of Basic and Clinical Pharmacology. LXXXIV: leukotriene receptor nomenclature, distribution, and pathophysiological functions.
    Bäck M; Dahlén SE; Drazen JM; Evans JF; Serhan CN; Shimizu T; Yokomizo T; Rovati GE
    Pharmacol Rev; 2011 Sep; 63(3):539-84. PubMed ID: 21771892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification, molecular cloning, expression, and characterization of a cysteinyl leukotriene receptor.
    Sarau HM; Ames RS; Chambers J; Ellis C; Elshourbagy N; Foley JJ; Schmidt DB; Muccitelli RM; Jenkins O; Murdock PR; Herrity NC; Halsey W; Sathe G; Muir AI; Nuthulaganti P; Dytko GM; Buckley PT; Wilson S; Bergsma DJ; Hay DW
    Mol Pharmacol; 1999 Sep; 56(3):657-63. PubMed ID: 10462554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological characterization of the first potent and selective antagonist at the cysteinyl leukotriene 2 (CysLT(2)) receptor.
    Wunder F; Tinel H; Kast R; Geerts A; Becker EM; Kolkhof P; Hütter J; Ergüden J; Härter M
    Br J Pharmacol; 2010 May; 160(2):399-409. PubMed ID: 20423349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cysteinyl leukotrienes acting via granule membrane-expressed receptors elicit secretion from within cell-free human eosinophil granules.
    Neves JS; Radke AL; Weller PF
    J Allergy Clin Immunol; 2010 Feb; 125(2):477-82. PubMed ID: 20159258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A kinetic binding study to evaluate the pharmacological profile of a specific leukotriene C(4) binding site not coupled to contraction in human lung parenchyma.
    Ravasi S; Capra V; Mezzetti M; Nicosia S; Rovati GE
    Mol Pharmacol; 2000 Jun; 57(6):1182-9. PubMed ID: 10825389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular cloning and functional characterization of murine cysteinyl-leukotriene 1 (CysLT(1)) receptors.
    Martin V; Sawyer N; Stocco R; Unett D; Lerner MR; Abramovitz M; Funk CD
    Biochem Pharmacol; 2001 Nov; 62(9):1193-200. PubMed ID: 11705452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential signaling defects associated with the M201V polymorphism in the cysteinyl leukotriene type 2 receptor.
    Brochu-Bourque A; Véronneau S; Rola-Pleszczynski M; Stankova J
    J Pharmacol Exp Ther; 2011 Feb; 336(2):431-9. PubMed ID: 20966037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional characterization of cysteinyl leukotriene CysLT(2) receptor on human coronary artery smooth muscle cells.
    Kamohara M; Takasaki J; Matsumoto M; Matsumoto Si ; Saito T; Soga T; Matsushime H; Furuichi K
    Biochem Biophys Res Commun; 2001 Oct; 287(5):1088-92. PubMed ID: 11587533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.